^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    irinotecan hydrochloride liposome injection (HR070803)

    i
    Other names: HR070803, HR 070803, HR-070803
    Associations

    News

    Trials
    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    Topoisomerase I inhibitor
    Related drugs:
    Associations

    News

    Trials
    6ms
    HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=778, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | N=522 --> 778
    Enrollment change • Combination therapy • Metastases
    |
    gemcitabine • 5-fluorouracil • albumin-bound paclitaxel • oxaliplatin • leucovorin calcium • irinotecan hydrochloride liposome injection (HR070803)
    7ms
    HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer (clinicaltrials.gov)
    P2, N=120, Not yet recruiting, The First Affiliated Hospital with Nanjing Medical University
    New P2 trial • Combination therapy
    |
    5-fluorouracil • leucovorin calcium • Teysuno (gimeracil/oteracil/tegafur) • Onivyde (nanoliposomal irinotecan) • irinotecan hydrochloride liposome injection (HR070803)
    10ms
    HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer (clinicaltrials.gov)
    P3, N=524, Not yet recruiting, Fudan University
    New P3 trial • Combination therapy
    |
    gemcitabine • 5-fluorouracil • capecitabine • oxaliplatin • leucovorin calcium • irinotecan hydrochloride liposome injection (HR070803)
    over1year
    A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer (clinicaltrials.gov)
    P2/3, N=606, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
    New P2/3 trial • Combination therapy • Metastases
    |
    Avastin (bevacizumab) • 5-fluorouracil • oxaliplatin • leucovorin calcium • irinotecan hydrochloride liposome injection (HR070803)
    over1year
    HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
    P3, N=522, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Combination therapy • Metastases
    |
    gemcitabine • 5-fluorouracil • albumin-bound paclitaxel • oxaliplatin • leucovorin calcium • irinotecan hydrochloride liposome injection (HR070803)